Imaging of Pancreatic Adenocarcinoma: Update on Staging/Resectability

Eric P. Tamm, Aparna Balachandran, Priya R. Bhosale, Matthew H. Katz, Jason B. Fleming, Jeffrey H. Lee, Gauri R. Varadhachary

Research output: Contribution to journalReview articlepeer-review

112 Scopus citations

Abstract

Because of the evolution of treatment strategies staging criteria for pancreatic cancer now emphasize arterial involvement for determining unresectable disease. Preoperative therapy may improve the likelihood of margin negative resections of borderline resectable tumors. Cross-sectional imaging is crucial for correctly staging patients. Magnetic resonance (MR) imaging and computed tomography (CT) are probably comparable, with MR imaging probably offering an advantage for identifying liver metastases. Positron emission tomography/CT and endoscopic ultrasound may be helpful for problem solving. Clear and concise reporting of imaging findings is important. Several national organizations are developing templates to standardize the reporting of imaging findings.

Original languageEnglish (US)
Pages (from-to)407-428
Number of pages22
JournalRadiologic Clinics of North America
Volume50
Issue number3
DOIs
StatePublished - May 2012

Keywords

  • Imaging
  • Pancreatic adenocarcinoma
  • Pancreatic cancer
  • Resectability
  • Staging
  • Treatment

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Imaging of Pancreatic Adenocarcinoma: Update on Staging/Resectability'. Together they form a unique fingerprint.

Cite this